These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

987 related items for PubMed ID: 12136475

  • 21. [Clinical, laboratory and morphological characteristics of mesangioproliferative glomerulonephritis].
    Tishkov I, Nedialkov A, Milkov V, Doĭchinov D, Minkova V.
    Vutr Boles; 1987; 26(5):91-5. PubMed ID: 3324489
    [Abstract] [Full Text] [Related]

  • 22. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
    Braun MC, West CD, Strife CF.
    Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
    [Abstract] [Full Text] [Related]

  • 23. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Dec; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 24. Immunosuppressive treatment of Berger's disease.
    Faedda R, Pirisi M, Satta A, Bosincu L, Bartoli E.
    Clin Pharmacol Ther; 1996 Nov; 60(5):561-7. PubMed ID: 8941029
    [Abstract] [Full Text] [Related]

  • 25. Immunopathologic findings in idiopathic renal hematuria.
    Kupor LR, Mullins JD, McPhaul JJ.
    Arch Intern Med; 1975 Sep; 135(9):1204-11. PubMed ID: 1164122
    [Abstract] [Full Text] [Related]

  • 26. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 27. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 28. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
    Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
    [Abstract] [Full Text] [Related]

  • 29. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D, Ahuja M, Shortland JR, Brown CB.
    Nephrol Dial Transplant; 1995 Aug; 10(7):1173-81. PubMed ID: 7478120
    [Abstract] [Full Text] [Related]

  • 30. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 31. Useful indicators for performing renal biopsy in adult patients with isolated microscopic haematuria.
    Shen P, He L, Jiang Y, Wang C, Chen M.
    Int J Clin Pract; 2007 May; 61(5):789-94. PubMed ID: 17362478
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 33. The clinical course of IgA nephropathy in adults.
    van der Peet J, Arisz L, Brentjens JR, Marrink J, Hoedemaeker PJ.
    Clin Nephrol; 1977 Aug; 8(2):335-40. PubMed ID: 142595
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
    Packham DK, Yan HD, Hewitson TD, Nicholls KM, Fairley KF, Kincaid-Smith P, Becker GJ.
    Clin Nephrol; 1996 Oct; 46(4):225-9. PubMed ID: 8905206
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [IgA mesangial glomerulonephritis (author's transl)].
    Pérez Garcia R, Jofre R, Vasconez F, López Gómez JM, Garcia de Vinuesa MS, Valderrábano F.
    Med Clin (Barc); 1981 Apr 10; 76(7):285-90. PubMed ID: 7253741
    [Abstract] [Full Text] [Related]

  • 39. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, Aljama P.
    Nephrol Dial Transplant; 2009 Mar 10; 24(3):886-91. PubMed ID: 18842673
    [Abstract] [Full Text] [Related]

  • 40. The spectrum of acute renal failure in IgA nephropathy.
    Wen YK, Chen ML.
    Ren Fail; 2010 May 10; 32(4):428-33. PubMed ID: 20446779
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.